The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

REGRESSIVE EST, CHLORPROMAZINE, AND GROUP THERAPY IN TREATMENT OF HOSPITALIZED CHRONIC SCHIZOPHRENICS

Published Online:https://doi.org/10.1176/ajp.115.4.354

1. A rating scale was devised for evaluating chronic mental patients.

2. By using this rating scale and certain other criteria, 19 sets of 5 carefully matched chronic schizophrenics were formed. Five groups of 19 patients each were randomly formed to compare the results of REST, REST plus group psychotherapy, chlorpromazine, and chlorpromazine plus group psychotherapy. One group contained matched controls.

3. REST was followed in 6 months by a significant lowering in rating score in comparison to the control group.

4. Weekly group therapy among REST patients restored them to a pre-treatment level.

5. Chlorpromazine resulted in a significant improvement in rating score in comparsion to the matched control group. Weekly group therapy resulted in slightly greater improvement, but it was not statistically significant.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.